State Plan for Medicaid: Inclusion of requirement for payment of certain costs related to testing for, preventing or treating human immunodeficiency virus or hepatitis C.
Nev. Rev. Stat. § 422.27235
in effect1. The Director shall include in the State Plan for Medicaid a requirement that the State pay the nonfederal share of expenditures incurred for:
(a) Any laboratory testing that is necessary for therapy that uses a drug approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus.
(b) The services of a pharmacist described in NRS 639.28085 . The State must provide reimbursement for such services at a rate equal to the rate of reimbursement provided to a physician, physician assistant or advanced practice registered nurse for similar services.
(c) Any service to test for, prevent or treat human immunodeficiency virus or hepatitis C provided by a provider of primary care if the service is covered when provided by a specialist and:
(1) The service is within the scope of practice of the provider of primary care; or
(2) The provider of primary care is capable of providing the service safely and effectively in consultation with a specialist and the provider engages in such consultation.
2. The Director shall include in the State Plan for Medicaid a requirement that the State reimburse an advanced practice registered nurse or a physician assistant for any service to test for, prevent or treat human immunodeficiency virus or hepatitis C at a rate equal to the rate of reimbursement provided to a physician for similar services.
3. As used in this section, primary care means the practice of family medicine, pediatrics, internal medicine, obstetrics and gynecology and midwifery.
Source: NV Statutes (Official Site)URL: https://www.leg.state.nv.us/nrs/NRS-422.htmlFetched: 10/4/2026